Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MARCHF10 divergent transcript (MARCHF10-DT) is a long non-coding RNA (lncRNA) gene. It does not code for a protein and is mainly classified as an lncRNA. There are no known, specific biological functions, disease associations, or drug interactions for this transcript at present. It is distinct from the nearby protein-coding gene MARCHF10 (Membrane Associated Ring-CH-Type Finger 10), which encodes an E3 ubiquitin ligase, but MARCHF10-DT itself has no reported role as a therapeutic target or in any well-characterized biological process.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MARCHF10 divergent transcript (MARCHF10-DT).